Drug intelligence / Profile preview

DuraMale

Development stage: Preclinical
Lead developer: Vitofarma
Administration: Oral

Overview

**DuraMale** is a Vitofarma herbal dietary-supplement product marketed for premature ejaculation. The product is described as an oral capsule containing a multi-herb formulation intended to delay ejaculation and support male sexual performance and libido. Its individual active botanical constituents, standardized composition, pharmacologic targets, and clinical efficacy have not been established in reliable public clinical sources.

Brand names: DuraMale

Beyond the preview

Go deeper on DuraMale.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on DuraMale.

Explore the full profile